Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized clinical trials

Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction

(2018) Otavio Berwanger et al.   JAMA Cardiology

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial

(2017) Leonardo de F.C. Guimarães et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Long-term pharmacodynamic effects of Ticagrelor versus Clopidogrel in fibrinolytic-treated STEMI patients undergoing early PCI

(2017) Andrew Yang et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Ticagrelor versus high dose clopidogrel in ST-segment elevation myocardial infarction patients with high platelet reactivity post fibrinolysis

(2015) Dimitrios Alexopoulos et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Evolution From Fibrinolytic Therapy to a Fibrinolytic Strategy for Patients With ST-Segment–Elevation Myocardial Infarction

(2014) Eric R. Bates   CIRCULATION

Platelet Function and Genetic Testing

(2013) Dominick J. Angiolillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

(2012) et al.   CIRCULATION

P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction

(2012) Alejandro Diego et al.   THROMBOSIS RESEARCH

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE